| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* William Harvey Research Institute, London, United Kingdom;
Post-Graduation in Morphology, Federal University of São Paulo, São Paulo, Brazil; and
Department of Biology, Instituto de Biociências, Letras e Ciências Exatas, São Paulo State University, São Paulo, Brazil
The recent appreciation of the role played by endogenous counterregulatory mechanisms in controlling the outcome of the host inflammatory response requires specific analysis of their spatial and temporal profiles. In this study, we have focused on the glucocorticoid-regulated anti-inflammatory mediator annexin 1. Induction of peritonitis in wild-type mice rapidly (4 h) produced the expected signs of inflammation, including marked activation of resident cells (e.g., mast cells), migration of blood-borne leukocytes, mirrored by blood neutrophilia. These changes subsided after 48–96 h. In annexin 1null mice, the peritonitis response was exaggerated (
40% at 4 h), with increased granulocyte migration and cytokine production. In blood leukocytes, annexin 1 gene expression was activated at 4, but not 24, h postzymosan, whereas protein levels were increased at both time points. Locally, endothelial and mast cell annexin 1 gene expression was not detectable in basal conditions, whereas it was switched on during the inflammatory response. The significance of annexin 1 system plasticity in the anti-inflammatory properties of dexamethasone was assessed. Clear induction of annexin 1 gene in response to dexamethasone treatment was evident in the circulating and migrated leukocytes, and in connective tissue mast cells; this was associated with the steroid failure to inhibit leukocyte trafficking, cytokine synthesis, and mast cell degranulation in the annexin 1null mouse. In conclusion, understanding how inflammation is brought under control will help clarify the complex interplay between pro- and anti-inflammatory pathways operating during the host response to injury and infection.
This article has been cited by other articles:
|
|
 |
|
  B. A. Babbin, M. G. Laukoetter, P. Nava, S. Koch, W. Y. Lee, C. T. Capaldo, E. Peatman, E. A. Severson, R. J. Flower, M. Perretti, et al. Annexin A1 Regulates Intestinal Mucosal Injury, Inflammation, and Repair J. Immunol., October 1, 2008; 181(7): 5035 - 5044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dalli, L. V. Norling, D. Renshaw, D. Cooper, K.-Y. Leung, and M. Perretti Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles Blood, September 15, 2008; 112(6): 2512 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Cash, R. Hart, A. Russ, J. P.C. Dixon, W. H. Colledge, J. Doran, A. G. Hendrick, M. B.L. Carlton, and D. R. Greaves Synthetic chemerin-derived peptides suppress inflammation through ChemR23 J. Exp. Med., April 14, 2008; 205(4): 767 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Meliton, N. M. Munoz, X. Zhu, and A. R. Leff Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks {beta}2-integrin adhesion in neutrophils J. Leukoc. Biol., February 1, 2008; 83(2): 344 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Urquhart, G. Rosignoli, D. Cooper, R. Motterlini, and M. Perretti Carbon Monoxide-Releasing Molecules Modulate Leukocyte-Endothelial Interactions under Flow J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 656 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Serhan, S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. J. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace Resolution of inflammation: state of the art, definitions and terms FASEB J, February 1, 2007; 21(2): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
